Why Has Synopsys Stopped Leading With Bad News?

Two years of Synopsys (SNPS) earnings calls show management changing what it explains. The company used to open on problems, some outside its control and some its own. The August 2026 call is built around a joint product with Ansys, agentic AI, and a new way to charge for its design IP. Most of that switch is earned, but parts of it are still a promise.

Synopsys Once Opened Its Calls With Bad News

Management used to point to underperformance in the IP business, where expected deals did not arrive, and to challenges at a major foundry customer that were having a sizable impact. The CEO said it plainly on an earlier call: “new export restrictions disrupted design starts in China.”

None of that comes up on the August 2026 call. China does not come up. The closest thing to the old worry is that design starts outside AI have stopped declining.

Synopsys Now Leads With Multiphysics Fusion And Agentic AI

In fiscal Q3 2026 the company launched Multiphysics Fusion, its first joint product with Ansys, which pulls thermal analysis into the chip design flow. Management put agentic AI forward as another growth vector. And it described a Factory 2 model for customized IP that adds royalties to licensing.

Design Automation, the segment that holds EDA, the chip design software business, runs about $7.7-7.9 billion a year. Design IP, the business the old story was about, is about $1.8 billion. Design Automation grew over the past year; Design IP did not. Whether that makes Synopsys a faster company or just a bigger one is a separate question.

The new levers are still ahead of the money. Management expects the joint Ansys capabilities to begin contributing to EDA growth in 2027. On Factory 2 it says it is in active discussions with multiple customers. No customer named, no number attached.

Is Synopsys Right That Design IP Has Turned?

This is where a silence could hide something. It mostly does not. Design IP shrank 8% over the past year, but that window still holds the quarters management used to lead with; fiscal Q3 2026 revenue of $474 million, up about 11% year over year, is what the turn rests on.

What changed is who says the risky part out loud. Management no longer leads its opening remarks with a problem. The sharpest worry on the August 2026 call came from an analyst, who asked whether AI-native chip design could one day bypass commercial EDA tools.

Synopsys raised its annual revenue and profit forecasts alongside the latest report, yet the stock lost about 10% over the past year while the S&P 500 returned 17%. If rising guidance is why you own it, check who else is raising guidance. The figure that settles this silence is Design IP revenue in fiscal Q4 2026, which management expects to grow sequentially again.

So Is Synopsys Still The Bet You Bought?

You bought a company that explained what went wrong. You now own one that describes what it is building. That is a different bet, and it asks you to trust execution before the numbers show it. If you would rather not judge that alone, our Five-Factor Stock Scorecard ranks every stock on growth, profitability, stability, resilience and valuation. And if you would rather not make the call at all, look at the Trefis High Quality Portfolio. That portfolio has a track record of outpacing the three major indices.